May 3, 2018 / 9:43 AM / 3 months ago

BRIEF-Esperite's Cell Factory Receives European Funding For 2nd Generation EVS Drug For Treatment Of Stroke

May 3 (Reuters) - ESPERITE NV:

* ESPERITE’S CELL FACTORY RECEIVED EUROPEAN FUNDING TO DEVELOP 2ND GENERATION EVS DRUG FOR TREATMENT OF STROKE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below